glp-1 receptor agonist atrial fibrillation risk use cuts regardless of weight loss GLP-1 Receptor Agonists in Heart
Description
The risk of bias in the included cohort studies was assessed using Newcastle-Ottawa Quality Assessment Form for Cohort Studies (NOS)
doi: 10.1016/s0006-8993(98)00584-8
These medications combine the effects of a GLP-1 receptor agonist with an agonist for GIP, another hormone produced by the small intestine
doi: 10.2337/dc24-S009 14 DruckerDJ
Diab Vasc
Lingvay, I
